Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

28.64
+0.25500.90%
Volume:4.18M
Turnover:119.71M
Market Cap:3.61B
PE:-6.13
High:29.06
Open:28.35
Low:28.12
Close:28.38
52wk High:43.15
52wk Low:25.77
Shares:126.00M
Float Shares:123.00M
Volume Ratio:0.66
T/O Rate:3.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:8.84
PE(LYR):-8.97

Loading ...

Viking Therapeutics is Maintained at Buy by Truist Securities

Dow Jones
·
2 hours ago

Analyst Maintains Buy Rating on Viking Therapeutics, Keeps VK2735-Driven Price Target at $70

TIPRANKS
·
Yesterday

Viking Therapeutics: VK2735 Maintenance Data Reinforces Obesity Franchise; Buy Rating and $102 Price Target Reiterated

TIPRANKS
·
Oct 06

Viking Therapeutics, Inc.: Reporting Results from Part 2 of Vanquish-1 Study in 2027

THOMSON REUTERS
·
Oct 06

Viking Therapeutics Announces Initiation of Vk2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

THOMSON REUTERS
·
Oct 06

Viking Therapeutics Slides As Cash Raise Spooks Wall Street

TIPRANKS
·
Oct 03

Weight Loss Maintenance Data Could Be A Big Test For Viking Therapeutics Stock (VKTX)

Simply Wall St.
·
Oct 03

23% Weight Loss, 27% Dropouts: How Strong Is Lilly's Phase 2 Combo, Really?

Options & Short Sell
·
Oct 01

Viking Therapeutics Raises Capital via Equity and Convertibles

TIPRANKS
·
Sep 29

Viking Therapeutics Closes USD 292.5 Million Convertible Senior Notes Offering

Reuters
·
Sep 29

Press Release: Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes

Dow Jones
·
Sep 29

Viking Therapeutics Rallies as Obesity Drug Hopes Rise

TIPRANKS
·
Sep 26

Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race

TIPRANKS
·
Sep 25

US Stocks on the MOVE-Charles River, Oracle, TD Synnex

Reuters
·
Sep 24

Viking Therapeutics Shares Down 15% After Co Prices Upsized Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

Movement Alert|Viking Therapeutics Falls 14.12% in Regular Trading, $400 Million Dual Offering Sparks Dilution Concerns After Sharp Rally

Market Focus
·
Sep 24

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Reuters
·
Sep 24

Viking Therapeutics, - Offering Size Increased to $275 Mln Common Stock and $225 Mln Notes

THOMSON REUTERS
·
Sep 24

Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

Movement Alert|Viking Therapeutics Falls 8.8% in Pre-Market Trading, $400 Million Dual Equity and Convertible Notes Offering Sparks Dilution Concerns

Market Focus
·
Sep 24